- Home
- TALO vs BEAM Comparison
TALO vs BEAM Comparison
Compare TALO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- BEAM
- Stock Information
- Founded
- TALO 2011
- BEAM 2017
- Country
- TALO United States
- BEAM United States
- Employees
- TALO N/A
- BEAM N/A
- Industry
- TALO Oil & Gas Production
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TALO Energy
- BEAM Health Care
- Exchange
- TALO Nasdaq
- BEAM Nasdaq
- Market Cap
- TALO 2.1B
- BEAM 1.9B
- IPO Year
- TALO N/A
- BEAM 2020
- Fundamental
- Price
- TALO $11.28
- BEAM $24.05
- Analyst Decision
- TALO Strong Buy
- BEAM Buy
- Analyst Count
- TALO 10
- BEAM 11
- Target Price
- TALO $18.05
- BEAM $45.90
- AVG Volume (30 Days)
- TALO 2.1M
- BEAM 1.3M
- Earning Date
- TALO 11-11-2024
- BEAM 11-05-2024
- Dividend Yield
- TALO N/A
- BEAM N/A
- EPS Growth
- TALO N/A
- BEAM N/A
- EPS
- TALO 0.45
- BEAM N/A
- Revenue
- TALO $1,871,460,000.00
- BEAM $349,643,000.00
- Revenue This Year
- TALO $37.97
- BEAM N/A
- Revenue Next Year
- TALO $0.55
- BEAM $6.04
- P/E Ratio
- TALO $24.81
- BEAM N/A
- Revenue Growth
- TALO 32.49
- BEAM 328.73
- 52 Week Low
- TALO $9.44
- BEAM $20.84
- 52 Week High
- TALO $14.80
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- TALO 54.66
- BEAM 46.67
- Support Level
- TALO $10.01
- BEAM $21.46
- Resistance Level
- TALO $12.13
- BEAM $32.29
- Average True Range (ATR)
- TALO 0.51
- BEAM 2.04
- MACD
- TALO 0.11
- BEAM 0.19
- Stochastic Oscillator
- TALO 50.35
- BEAM 23.92
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.